Cenderitide, with the CAS number 507289-11-4, is a synthetic peptide that functions as a dual agonist for the receptors of both glucagon and GLP-1 (glucagon-like peptide-1). This compound is primarily investigated for its potential therapeutic applications in the management of type 2 diabetes and obesity. Cenderitide is designed to enhance insulin secretion, improve glycemic control, and promote weight loss by mimicking the physiological effects of these hormones. Its unique mechanism of action allows it to stimulate glucose-dependent insulin release while also suppressing glucagon secretion, which helps to reduce hepatic glucose production. Additionally, Cenderitide may have beneficial effects on cardiovascular health and weight management. As a peptide, it is typically administered via injection due to its susceptibility to degradation in the gastrointestinal tract. Ongoing research aims to further elucidate its pharmacokinetics, efficacy, and safety profile in clinical settings.

Cenderitide

507289-11-4: Cenderitide, with the CAS number 507289-11-4, is a synthetic peptide that functions as a dual agonist for the receptors of both glucagon and GLP-1 (glucagon-like peptide-1). This compound is primarily investigated for its potential therapeutic applications in the management of type 2 diabetes and obesity. Cenderitide is designed to enhance insulin secretion, improve glycemic control, and promote weight loss by mimicking the physiological effects of these hormones. Its unique mechanism of action allows it to stimulate glucose-dependent insulin release while also suppressing glucagon secretion, which helps to reduce hepatic glucose production. Additionally, Cenderitide may have beneficial effects on cardiovascular health and weight management. As a peptide, it is typically administered via injection due to its susceptibility to degradation in the gastrointestinal tract. Ongoing research aims to further elucidate its pharmacokinetics, efficacy, and safety profile in clinical settings.

<p>Cenderitide fuses CNP with DNP, stimulates pGC-A/B, ups cGMP, curbs aldosterone, and aids GFR, not affecting BP—used in heart failure studies.</p>

CAS 507289-11-4

Cenderitide

Cenderitide

Ref: TM-T76334